RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients.

Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients.

Add to Collection
2015 Jan-Feb Others SR Shetty, S Kumar, RP Mathur, KH Sharma… - Indian heart …, 2015 - Elsevier

Full Author : ['Shetty, Sadanand R', 'Kumar, Soumitra', 'Mathur, R P', 'Sharma, Kamal H', 'Jaiswal, Ashok D']
Journal Title : Indian heart journal
Chapter : Section3
Journal Year : 2015
Cited by : 43.0

Saroglitazar is a dual PPAR alpha/gamma agonist approved in India for the management of diabetic dyslipidemia. AIMS: The objective of this study was to evaluate the safety and efficacy of saroglitazar 4 mg once daily in clinical practice. METHODS: This wa..... Read More

Keywords : ["indian diabetic dyslipidemia patient", "observational study", "saroglitazar", "safety", "evaluate", "efficacy"]
PubMed Link : https://www.sciencedirect.com/science/article/pii/S0019483215000115
Google Scholar Link : https://scholar.google.com/scholar?cites=16065261768314990846&as_sdt=80005&sciodt=0,11&hl=en&num=20